Clinical Trials Logo

Cancer of Cervix clinical trials

View clinical trials related to Cancer of Cervix.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02312804 Withdrawn - Tumors Clinical Trials

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Start date: January 2015
Phase: Phase 1
Study type: Interventional

This study will be conducted using 3+3 design and includes, a dose escalation part to define the MTDfRP2D for the combination of BGJ398 and carboplatin/paclitaxel, and a dose expansion part to treat another 12 patients (only cervix cancer) to further evaluate safety of this combination. Safety, tolerability and MTD will be determined in the dose escalation part of the study. The dose expansion will additionally investigate preliminary anti-tumor efficacy in cervical cancer. The dosing cycle is 21 days.